{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:38:58Z","timestamp":1793338738124,"version":"4.5.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070264, 82100764"],"award-info":[{"award-number":["82070264, 82100764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070264, 82100764"],"award-info":[{"award-number":["82070264, 82100764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xi 'an Science and Technology Bureau Project","award":["24YXYJ0138"],"award-info":[{"award-number":["24YXYJ0138"]}]},{"name":"Department of Science and Technology of Shaanxi Province","award":["2024SF-LCZX05, 2022ZDLSF01-09, 2023-CX-PT-06"],"award-info":[{"award-number":["2024SF-LCZX05, 2022ZDLSF01-09, 2023-CX-PT-06"]}]},{"name":"Department of Science and Technology of Shaanxi Province","award":["2024SF-LCZX05, 2022ZDLSF01-09, 2023-CX-PT-06"],"award-info":[{"award-number":["2024SF-LCZX05, 2022ZDLSF01-09, 2023-CX-PT-06"]}]},{"name":"Xijing Research Boosting Program","award":["XJZT24LY40"],"award-info":[{"award-number":["XJZT24LY40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00618-x","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:21:31Z","timestamp":1741623691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction"],"prefix":"10.1186","volume":"20","author":[{"given":"Jun","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"20","key":"618_CR1","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348(20):2007\u201318.","journal-title":"N Engl J Med"},{"issue":"20","key":"618_CR2","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"WJ Paulus","year":"2007","unstructured":"Paulus WJ, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539\u201350.","journal-title":"Eur Heart J"},{"issue":"10","key":"618_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur J Heart Fail. 2008;10(10):933\u201389.","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"618_CR4","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"10","key":"618_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591\u2013602.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"618_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"618_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","volume":"4","author":"F Ceia","year":"2002","unstructured":"Ceia F, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002;4(4):531\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"618_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","volume":"20","author":"V Regitz-Zagrosek","year":"2023","unstructured":"Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol. 2023;20(4):236\u201347.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"618_CR9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","volume":"75","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G. Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol. 2020;75(9):1074\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"618_CR10","doi-asserted-by":"publisher","first-page":"e003921","DOI":"10.1161\/JAHA.116.003921","volume":"5","author":"CE Ndumele","year":"2016","unstructured":"Ndumele CE, et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc. 2016;5(8):e003921.","journal-title":"J Am Heart Assoc"},{"key":"618_CR11","unstructured":"Collaboration, N.C.D.R.F., Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 2024. 403(10431): p. 1027\u20131050."},{"issue":"3","key":"618_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","volume":"7","author":"LM Jaacks","year":"2019","unstructured":"Jaacks LM, et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7(3):231\u201340.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"618_CR13","doi-asserted-by":"crossref","unstructured":"Lovejoy JC, Sainsbury A, and G. Stock Conference Working, Sex differences in obesity and the regulation of energy homeostasis. Obes Rev. 2009; 10(2):154\u201367.","DOI":"10.1111\/j.1467-789X.2008.00529.x"},{"issue":"3","key":"618_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278\u2013316.","journal-title":"Endocr Rev"},{"issue":"2","key":"618_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/EJE-12-0143","volume":"167","author":"WL Awa","year":"2012","unstructured":"Awa WL, et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German\/Austrian DPV database. Eur J Endocrinol. 2012;167(2):245\u201354.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"618_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.numecd.2011.09.002","volume":"23","author":"V Wietlisbach","year":"2013","unstructured":"Wietlisbach V, et al. The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project. Nutr Metab Cardiovasc Dis. 2013;23(5):432\u201342.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"618_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, et al. Prevalence and trends in obesity among US adults, 1999\u20132008. JAMA. 2010;303(3):235\u201341.","journal-title":"JAMA"},{"issue":"12","key":"618_CR18","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation. 2018;137(12):e67\u2013492.","journal-title":"Circulation"},{"issue":"1","key":"618_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, et al. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136(1):6\u201319.","journal-title":"Circulation"},{"issue":"19","key":"618_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/eurheartj\/eht117","volume":"34","author":"BA Borlaug","year":"2013","unstructured":"Borlaug BA. Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases. Eur Heart J. 2013;34(19):1393\u20135.","journal-title":"Eur Heart J"},{"issue":"1","key":"618_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","volume":"315","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315(1):36\u201346.","journal-title":"JAMA"},{"issue":"3","key":"618_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324\u201331.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"618_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701\u20139.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"618_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","volume":"6","author":"JE Ho","year":"2013","unstructured":"Ho JE, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279\u201386.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"618_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/oby.20168","volume":"21","author":"Y Koshino","year":"2013","unstructured":"Koshino Y, et al. Changes in myocardial mechanics in patients with obesity following major weight loss after bariatric surgery. Obesity (Silver Spring). 2013;21(6):1111\u20138.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"618_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox CS, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007;116(1):39\u201348.","journal-title":"Circulation"},{"issue":"6","key":"618_CR27","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1210\/jc.2003-031619","volume":"89","author":"I Ferreira","year":"2004","unstructured":"Ferreira I, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89(6):2632\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"618_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pcad.2013.09.003","volume":"56","author":"MA Alpert","year":"2014","unstructured":"Alpert MA, et al. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56(4):391\u2013400.","journal-title":"Prog Cardiovasc Dis"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2261-12-3","volume":"12","author":"JI Recio-Rodriguez","year":"2012","unstructured":"Recio-Rodriguez JI, et al. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012;12:3.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"618_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10741-021-10103-y","volume":"27","author":"F Triposkiadis","year":"2022","unstructured":"Triposkiadis F, et al. Obesity, inflammation, and heart failure: links and misconceptions. Heart Fail Rev. 2022;27(2):407\u201318.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"618_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ejhf.1167","volume":"20","author":"M Packer","year":"2018","unstructured":"Packer M. Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction. Eur J Heart Fail. 2018;20(5):873\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"618_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jchf.2018.01.009","volume":"6","author":"M Packer","year":"2018","unstructured":"Packer M, Kitzman DW. Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Fail. 2018;6(8):633\u20139.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"618_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jchf.2018.09.006","volume":"6","author":"A Pandey","year":"2018","unstructured":"Pandey A, et al. Physical activity, fitness, and obesity in heart failure with preserved ejection fraction. JACC Heart Fail. 2018;6(12):975\u201382.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"618_CR34","doi-asserted-by":"publisher","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","volume":"287","author":"CM Boustany","year":"2004","unstructured":"Boustany CM, et al. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004;287(4):R943\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"618_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991\u20131006.","journal-title":"Circ Res"},{"issue":"7","key":"618_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030142","volume":"13","author":"JM Brown","year":"2024","unstructured":"Brown JM. Adverse effects of aldosterone: beyond blood pressure. J Am Heart Assoc. 2024;13(7): e030142.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"618_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/ajh\/hpw003","volume":"29","author":"W Kawarazaki","year":"2016","unstructured":"Kawarazaki W, Fujita T. The role of aldosterone in obesity-related hypertension. Am J Hypertens. 2016;29(4):415\u201323.","journal-title":"Am J Hypertens"},{"issue":"8","key":"618_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","volume":"8","author":"KE Koepp","year":"2020","unstructured":"Koepp KE, et al. Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction. JACC Heart Fail. 2020;8(8):657\u201366.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"618_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/14779072.6.3.343","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays HE, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343\u201368.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"618_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nm809","volume":"9","author":"P Ciana","year":"2003","unstructured":"Ciana P, et al. In vivo imaging of transcriptionally active estrogen receptors. Nat Med. 2003;9(1):82\u20136.","journal-title":"Nat Med"},{"key":"618_CR41","doi-asserted-by":"crossref","unstructured":"Chatterjee K, Primary diastolic heart failure. Am J Geriatr Cardiol. 2002; 11(3):178\u201387; quiz 188\u20139.","DOI":"10.1111\/j.1076-7460.2002.00051.x"},{"issue":"5","key":"618_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ejechocard\/jen117","volume":"9","author":"CA Garza","year":"2008","unstructured":"Garza CA, et al. Major weight loss prevents long-term left atrial enlargement in patients with morbid and extreme obesity. Eur J Echocardiogr. 2008;9(5):587\u201393.","journal-title":"Eur J Echocardiogr"},{"issue":"12","key":"618_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","volume":"133","author":"F Grodstein","year":"2000","unstructured":"Grodstein F, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133(12):933\u201341.","journal-title":"Ann Intern Med"},{"issue":"5","key":"618_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2337\/diab.45.5.687","volume":"45","author":"K Clement","year":"1996","unstructured":"Clement K, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes. 1996;45(5):687\u201390.","journal-title":"Diabetes"},{"issue":"34","key":"618_CR45","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1093\/eurheartj\/ehz391","volume":"40","author":"GC Chen","year":"2019","unstructured":"Chen GC, et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019;40(34):2849\u201355.","journal-title":"Eur Heart J"},{"issue":"5","key":"618_CR46","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/ajcn\/55.5.950","volume":"55","author":"CJ Ley","year":"1992","unstructured":"Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55(5):950\u20134.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"618_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.yfrne.2009.03.004","volume":"30","author":"H Shi","year":"2009","unstructured":"Shi H, Seeley RJ, Clegg DJ. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol. 2009;30(3):396\u2013404.","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"618_CR48","first-page":"838","volume":"57","author":"GB Phillips","year":"2008","unstructured":"Phillips GB, Jing T, Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women Metabolism. 2008;57(6):838\u201344.","journal-title":"Studies in women Metabolism"},{"issue":"3","key":"618_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.maturitas.2009.11.004","volume":"65","author":"R Eshtiaghi","year":"2010","unstructured":"Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65(3):262\u20136.","journal-title":"Maturitas"},{"issue":"2","key":"618_CR50","first-page":"123","volume":"6","author":"M Garaulet","year":"2002","unstructured":"Garaulet M, et al. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J Nutr Health Aging. 2002;6(2):123\u20136.","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"618_CR51","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2008.25","volume":"32","author":"JC Lovejoy","year":"2008","unstructured":"Lovejoy JC, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949\u201358.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"618_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593\u2013606.","journal-title":"Nat Rev Cardiol"},{"key":"618_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-11488-6_9","volume":"1127","author":"G Berg","year":"2019","unstructured":"Berg G, et al. Epicardial adipose tissue in cardiovascular disease. Adv Exp Med Biol. 2019;1127:131\u201343.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"618_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000582","volume":"3","author":"TP Fitzgibbons","year":"2014","unstructured":"Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc. 2014;3(2): e000582.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"618_CR55","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1016\/j.mayocp.2021.08.009","volume":"96","author":"FL Gersh","year":"2021","unstructured":"Gersh FL, et al. The renin-angiotensin-aldosterone system in postmenopausal women: the promise of hormone therapy. Mayo Clin Proc. 2021;96(12):3130\u201341.","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"618_CR56","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","volume":"72","author":"J Tromp","year":"2018","unstructured":"Tromp J, et al. Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2018;72(10):1081\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"618_CR57","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2021.04.003","volume":"77","author":"S Kenchaiah","year":"2021","unstructured":"Kenchaiah S, et al. Pericardial fat and the risk of heart failure. J Am Coll Cardiol. 2021;77(21):2638\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"618_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11906-019-0939-6","volume":"21","author":"TH Le Jemtel","year":"2019","unstructured":"Le Jemtel TH, et al. Epicardial adipose tissue and cardiovascular disease. Curr Hypertens Rep. 2019;21(5):36.","journal-title":"Curr Hypertens Rep"},{"key":"618_CR59","doi-asserted-by":"crossref","unstructured":"Vyas V, et al., Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation. JCI Insight. 2021; 6(16).","DOI":"10.1172\/jci.insight.145495"},{"issue":"11","key":"618_CR60","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2019.12.069","volume":"75","author":"JA Chirinos","year":"2020","unstructured":"Chirinos JA, et al. Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2020;75(11):1281\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"618_CR61","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367.","journal-title":"Pharmacol Rev"},{"key":"618_CR62","doi-asserted-by":"crossref","unstructured":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: Erratum. J Hypertens. 2019; 37(1):226.","DOI":"10.1097\/HJH.0000000000002017"},{"issue":"5\u20136","key":"618_CR63","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00103-013-1669-6","volume":"56","author":"H Neuhauser","year":"2013","unstructured":"Neuhauser H, Thamm M, Ellert U. Blood pressure in Germany 2008\u20132011: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5\u20136):795\u2013801.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"8","key":"618_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC Heart Fail. 2017;5(8):543\u201351.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"618_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0025-6196(11)63649-5","volume":"73","author":"SN Hayes","year":"1998","unstructured":"Hayes SN, Taler SJ. Hypertension in women: current understanding of gender differences. Mayo Clin Proc. 1998;73(2):157\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"618_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.jhh.1001120","volume":"15","author":"C Gasse","year":"2001","unstructured":"Gasse C, et al. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984\u20131995. J Hum Hypertens. 2001;15(1):27\u201336.","journal-title":"J Hum Hypertens"},{"key":"618_CR67","first-page":"1","volume":"220","author":"SS Yoon","year":"2015","unstructured":"Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011\u20132014. NCHS Data Brief. 2015;220:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"7","key":"618_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1042\/CS20130140","volume":"125","author":"R Maranon","year":"2013","unstructured":"Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci. 2013;125(7):311\u20138.","journal-title":"Clin Sci"},{"issue":"4","key":"618_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1871522211108040255","volume":"11","author":"MR Meyer","year":"2011","unstructured":"Meyer MR, Prossnitz ER, Barton M. GPER\/GPR30 and regulation of vascular tone and blood pressure. Immunol Endocr Metab Agents Med Chem. 2011;11(4):255\u201361.","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"1","key":"618_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/HYPERTENSIONAHA.108.120022","volume":"54","author":"M Barton","year":"2009","unstructured":"Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension. 2009;54(1):11\u20138.","journal-title":"Hypertension"},{"issue":"23","key":"618_CR71","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801\u201311.","journal-title":"N Engl J Med"},{"key":"618_CR72","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.04013","volume":"4","author":"JK Kim","year":"2006","unstructured":"Kim JK, Levin ER. Estrogen signaling in the cardiovascular system. Nucl Recept Signal. 2006;4: e013.","journal-title":"Nucl Recept Signal"},{"issue":"11","key":"618_CR73","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1073\/pnas.91.11.5212","volume":"91","author":"CP Weiner","year":"1994","unstructured":"Weiner CP, et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994;91(11):5212\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"618_CR74","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/01.HYP.0000098661.37637.89","volume":"42","author":"J Widder","year":"2003","unstructured":"Widder J, et al. Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension. 2003;42(5):991\u20136.","journal-title":"Hypertension"},{"issue":"5554","key":"618_CR75","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.1065250","volume":"295","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002;295(5554):505\u20138.","journal-title":"Science"},{"issue":"4","key":"618_CR76","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/cvr\/cvm081","volume":"77","author":"V Jazbutyte","year":"2008","unstructured":"Jazbutyte V, et al. Ligand-dependent activation of ERbeta lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res. 2008;77(4):774\u201381.","journal-title":"Cardiovasc Res"},{"key":"618_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsbmb.2017.05.006","volume":"176","author":"NC Fredette","year":"2018","unstructured":"Fredette NC, Meyer MR, Prossnitz ER. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation. J Steroid Biochem Mol Biol. 2018;176:65\u201372.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"618_CR78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.pcad.2006.08.011","volume":"49","author":"V Regitz-Zagrosek","year":"2007","unstructured":"Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis. 2007;49(4):241\u201351.","journal-title":"Prog Cardiovasc Dis"},{"issue":"20","key":"618_CR79","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557\u201362.","journal-title":"JAMA"},{"issue":"5","key":"618_CR80","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00059-005-2718-1","volume":"30","author":"V Regitz-Zagrosek","year":"2005","unstructured":"Regitz-Zagrosek V, Lehmkuhl E. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen. Herz. 2005;30(5):356\u201367.","journal-title":"Herz"},{"issue":"1","key":"618_CR81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","volume":"13","author":"CS Lam","year":"2011","unstructured":"Lam CS, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18\u201328.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"618_CR82","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s11739-022-03019-4","volume":"17","author":"M Arcopinto","year":"2022","unstructured":"Arcopinto M, et al. What have we learned so far from the sex\/gender issue in heart failure? An overview of current evidence. Intern Emerg Med. 2022;17(6):1589\u201398.","journal-title":"Intern Emerg Med"},{"issue":"27","key":"618_CR83","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"6","key":"618_CR84","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2017;136(6):e137\u201361.","journal-title":"Circulation"},{"issue":"5","key":"618_CR85","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7326\/0003-4819-147-5-200709040-00006","volume":"147","author":"PM Okin","year":"2007","unstructured":"Okin PM, et al. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med. 2007;147(5):311\u20139.","journal-title":"Ann Intern Med"},{"issue":"17","key":"618_CR86","first-page":"e484","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines. Circulation. 2018;138(17):e484\u2013594.","journal-title":"Circulation"},{"issue":"5","key":"618_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","volume":"171","author":"S Sciarretta","year":"2011","unstructured":"Sciarretta S, et al. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med. 2011;171(5):384\u201394.","journal-title":"Arch Intern Med"},{"issue":"3","key":"618_CR88","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"618_CR89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (ADHERE) database. J Am Coll Cardiol. 2006;47(1):76\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"618_CR90","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","volume":"119","author":"DS Lee","year":"2009","unstructured":"Lee DS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009;119(24):3070\u20137.","journal-title":"Circulation"},{"issue":"9","key":"618_CR91","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ejhf.327","volume":"17","author":"DP Kao","year":"2015","unstructured":"Kao DP, et al. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015;17(9):925\u201335.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"618_CR92","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","volume":"15","author":"J Slivnick","year":"2019","unstructured":"Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531\u201341.","journal-title":"Heart Fail Clin"},{"key":"618_CR93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-med-041316-090654","volume":"69","author":"JD Gladden","year":"2018","unstructured":"Gladden JD, Chaanine AH, Redfield MM. Heart failure with preserved ejection fraction. Annu Rev Med. 2018;69:65\u201379.","journal-title":"Annu Rev Med"},{"issue":"5","key":"618_CR94","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10741-018-9698-8","volume":"23","author":"M Tadic","year":"2018","unstructured":"Tadic M, et al. The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? Heart Fail Rev. 2018;23(5):631\u20139.","journal-title":"Heart Fail Rev"},{"issue":"12","key":"618_CR95","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.recesp.2016.10.014","volume":"69","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed). 2016;69(12):1167.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"618_CR96","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0735-1097(02)02710-9","volume":"41","author":"DL Crabbe","year":"2003","unstructured":"Crabbe DL, et al. Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol. 2003;41(2):300\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"618_CR97","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000176895","volume":"86","author":"GP Aurigemma","year":"1995","unstructured":"Aurigemma GP, Gaasch WH. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology. 1995;86(4):310\u20137.","journal-title":"Cardiology"},{"issue":"9","key":"618_CR98","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/CIRCULATIONAHA.110.937839","volume":"122","author":"CS Lam","year":"2010","unstructured":"Lam CS, et al. Aortic root remodeling over the adult life course: longitudinal data from the Framingham heart study. Circulation. 2010;122(9):884\u201390.","journal-title":"Circulation"},{"issue":"15","key":"618_CR99","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","volume":"112","author":"MM Redfield","year":"2005","unstructured":"Redfield MM, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation. 2005;112(15):2254\u201362.","journal-title":"Circulation"},{"issue":"2","key":"618_CR100","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1378\/chest.09-1140","volume":"137","author":"DB Badesch","year":"2010","unstructured":"Badesch DB, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137(2):376\u201387.","journal-title":"Chest"},{"issue":"3","key":"618_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","volume":"4","author":"T Thenappan","year":"2011","unstructured":"Thenappan T, et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2011;4(3):257\u201365.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"618_CR102","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","volume":"73","author":"K McHugh","year":"2019","unstructured":"McHugh K, et al. Heart failure with preserved ejection fraction and diabetes: JACC State-of-the-art review. J Am Coll Cardiol. 2019;73(5):602\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"618_CR103","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/pop.2015.0181","volume":"20","author":"WR Rowley","year":"2017","unstructured":"Rowley WR, et al. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20(1):6\u201312.","journal-title":"Popul Health Manag"},{"issue":"10397","key":"618_CR104","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBDD Collaborators","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"issue":"8","key":"618_CR105","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, et al. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879\u201384.","journal-title":"Diabetes Care"},{"issue":"8","key":"618_CR106","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","volume":"26","author":"DS Bell","year":"2003","unstructured":"Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care. 2003;26(8):2433\u201341.","journal-title":"Diabetes Care"},{"issue":"11","key":"618_CR107","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","volume":"29","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(11):1377\u201385.","journal-title":"Eur Heart J"},{"issue":"6","key":"618_CR108","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00125-023-05913-8","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer A, Leutner M, Harreiter J. Correction to: sex differences in type 2 diabetes. Diabetologia. 2023;66(6):1165.","journal-title":"Diabetologia"},{"issue":"9785","key":"618_CR109","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31\u201340.","journal-title":"Lancet"},{"key":"618_CR110","doi-asserted-by":"crossref","unstructured":"Group DS, Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003; 26(1):61\u20139","DOI":"10.2337\/diacare.26.1.61"},{"issue":"4","key":"618_CR111","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2337\/dc18-2029","volume":"42","author":"T Du","year":"2019","unstructured":"Du T, et al. Sex differences in cardiovascular risk profile from childhood to midlife between individuals who did and did not develop diabetes at follow-up: the Bogalusa heart study. Diabetes Care. 2019;42(4):635\u201343.","journal-title":"Diabetes Care"},{"issue":"8","key":"618_CR112","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","volume":"57","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542\u201351.","journal-title":"Diabetologia"},{"issue":"1","key":"618_CR113","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.","journal-title":"Nat Rev Dis Primers"},{"key":"618_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1361","volume":"369","author":"E Vounzoulaki","year":"2020","unstructured":"Vounzoulaki E, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369: m1361.","journal-title":"BMJ"},{"issue":"1","key":"618_CR115","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34(1):29\u201334.","journal-title":"Am J Cardiol"},{"issue":"1","key":"618_CR116","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12916-019-1355-0","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med. 2019;17(1):136.","journal-title":"BMC Med"},{"issue":"4","key":"618_CR117","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/CIRCHEARTFAILURE.108.794008","volume":"1","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, et al. Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail. 2008;1(4):234\u201341.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"618_CR118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/14017430903312438","volume":"44","author":"C Andersson","year":"2010","unstructured":"Andersson C, et al. Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure. Scand Cardiovasc J. 2010;44(1):37\u201344.","journal-title":"Scand Cardiovasc J"},{"issue":"3","key":"618_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.amjcard.2009.09.041","volume":"105","author":"D Aguilar","year":"2010","unstructured":"Aguilar D, et al. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010;105(3):373\u20137.","journal-title":"Am J Cardiol"},{"issue":"1","key":"618_CR120","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-023-02023-y","volume":"22","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Brunton SA, Rangaswami J. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review. Cardiovasc Diabetol. 2023;22(1):316.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"618_CR121","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","volume":"134","author":"HJ Heerspink","year":"2016","unstructured":"Heerspink HJ, et al. Sodium Glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation. 2016;134(10):752\u201372.","journal-title":"Circulation"},{"key":"618_CR122","doi-asserted-by":"crossref","unstructured":"Smaha LA and American Heart A, The american heart association get with the guidelines program. Am Heart J. 2004; 148(5 Suppl): pp. S46\u20138.","DOI":"10.1016\/j.ahj.2004.09.015"},{"issue":"11","key":"618_CR123","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJMc1600140","volume":"374","author":"B Zinman","year":"2016","unstructured":"Zinman B, Lachin JM, Inzucchi SE. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2016;374(11):1094.","journal-title":"N Engl J Med"},{"issue":"11","key":"618_CR124","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/ejhf.933","volume":"19","author":"J Butler","year":"2017","unstructured":"Butler J, et al. The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. Eur J Heart Fail. 2017;19(11):1390\u2013400.","journal-title":"Eur J Heart Fail"},{"key":"618_CR125","doi-asserted-by":"crossref","unstructured":"Salvatore T, et al., An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors. Int J Mol Sci. 2022; 23(7).","DOI":"10.3390\/ijms23073651"},{"issue":"1","key":"618_CR126","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","volume":"19","author":"L Ni","year":"2020","unstructured":"Ni L, et al. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol. 2020;19(1):98.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"618_CR127","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","volume":"65","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini E, et al. Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes. 2016;65(5):1190\u20135.","journal-title":"Diabetes"},{"issue":"5","key":"618_CR128","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/cvr\/cvae047","volume":"120","author":"A Preda","year":"2024","unstructured":"Preda A, et al. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovasc Res. 2024;120(5):443\u201360.","journal-title":"Cardiovasc Res"},{"key":"618_CR129","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","volume":"104","author":"TM Lee","year":"2017","unstructured":"Lee TM, Chang NC, Lin SZ. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic Biol Med. 2017;104:298\u2013310.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"618_CR130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol. 2019;18(1):15.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"618_CR131","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","volume":"3","author":"A Dei Cas","year":"2015","unstructured":"Dei Cas A, et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015;3(2):136\u201345.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"618_CR132","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358.","journal-title":"Physiol Rev"},{"issue":"3","key":"618_CR133","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1748-1716.2006.01581.x","volume":"187","author":"DE Flanagan","year":"2006","unstructured":"Flanagan DE, et al. Gender differences in the insulin-like growth factor axis response to a glucose load. Acta Physiol (Oxf). 2006;187(3):371\u20138.","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"618_CR134","doi-asserted-by":"publisher","first-page":"H779","DOI":"10.1152\/ajpheart.00141.2013","volume":"305","author":"ME Reichelt","year":"2013","unstructured":"Reichelt ME, et al. Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus. Am J Physiol Heart Circ Physiol. 2013;305(6):H779\u201392.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"618_CR135","first-page":"88","volume":"28","author":"L Ryden","year":"2007","unstructured":"Ryden L, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary the task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European association for the study of diabetes (EASD). Eur Heart J. 2007;28(1):88\u2013136.","journal-title":"Eur Heart J"},{"issue":"8","key":"618_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104771","volume":"9","author":"B Luo","year":"2014","unstructured":"Luo B, et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS One. 2014;9(8): e104771.","journal-title":"PLoS One"},{"issue":"4","key":"618_CR137","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"4","key":"618_CR138","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/dme.13301","volume":"34","author":"SK Park","year":"2017","unstructured":"Park SK, et al. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes. Diabet Med. 2017;34(4):531\u20138.","journal-title":"Diabet Med"},{"issue":"8","key":"618_CR139","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2362.1993.tb00792.x","volume":"23","author":"C Walton","year":"1993","unstructured":"Walton C, et al. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest. 1993;23(8):466\u201373.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"618_CR140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-5122(97)00051-0","volume":"28","author":"JM Malacara","year":"1997","unstructured":"Malacara JM, et al. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile. Maturitas. 1997;28(1):35\u201345.","journal-title":"Maturitas"},{"issue":"3","key":"618_CR141","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2337\/dc13-1986","volume":"37","author":"D Appiah","year":"2014","unstructured":"Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care. 2014;37(3):725\u201333.","journal-title":"Diabetes Care"},{"issue":"10","key":"618_CR142","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/diacare.21.10.1589","volume":"21","author":"MA Espeland","year":"1998","unstructured":"Espeland MA, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI investigators postmenopausal estrogen\/progestin interventions. Diabetes Care. 1998;21(10):1589\u201395.","journal-title":"Diabetes Care"},{"issue":"5","key":"618_CR143","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","volume":"8","author":"SR Salpeter","year":"2006","unstructured":"Salpeter SR, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006;8(5):538\u201354.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"618_CR144","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975\u20134011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"618_CR145","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.metabol.2008.08.004","volume":"58","author":"V Saengsirisuwan","year":"2009","unstructured":"Saengsirisuwan V, et al. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism. 2009;58(1):38\u201347.","journal-title":"Metabolism"},{"issue":"2","key":"618_CR146","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2337\/dc06-1772","volume":"30","author":"RP Donahue","year":"2007","unstructured":"Donahue RP, et al. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York study. Diabetes Care. 2007;30(2):354\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"618_CR147","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00125-011-2284-4","volume":"55","author":"SG Wannamethee","year":"2012","unstructured":"Wannamethee SG, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British regional heart study and British women\u2019s heart health study. Diabetologia. 2012;55(1):80\u20137.","journal-title":"Diabetologia"},{"issue":"4","key":"618_CR148","doi-asserted-by":"publisher","first-page":"H742","DOI":"10.1152\/ajpheart.00535.2016","volume":"312","author":"I Hunter","year":"2017","unstructured":"Hunter I, et al. Cardiovascular function in male and female JCR:LA-cp rats: effect of high-fat\/high-sucrose diet. Am J Physiol Heart Circ Physiol. 2017;312(4):H742\u201351.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"618_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087941","volume":"9","author":"G Kilic","year":"2014","unstructured":"Kilic G, et al. The islet estrogen receptor-alpha is induced by hyperglycemia and protects against oxidative stress-induced insulin-deficient diabetes. PLoS One. 2014;9(2): e87941.","journal-title":"PLoS One"},{"issue":"2","key":"618_CR150","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00125-012-2764-1","volume":"56","author":"S Liu","year":"2013","unstructured":"Liu S, et al. Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes. Diabetologia. 2013;56(2):370\u201381.","journal-title":"Diabetologia"},{"issue":"10","key":"618_CR151","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.2337\/db09-0257","volume":"58","author":"S Liu","year":"2009","unstructured":"Liu S, et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes. 2009;58(10):2292\u2013302.","journal-title":"Diabetes"},{"issue":"1","key":"618_CR152","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.celrep.2018.06.019","volume":"24","author":"B Xu","year":"2018","unstructured":"Xu B, et al. Estrogens promote misfolded proinsulin degradation to protect insulin production and delay diabetes. Cell Rep. 2018;24(1):181\u201396.","journal-title":"Cell Rep"},{"issue":"7","key":"618_CR153","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","volume":"14","author":"A Andersen","year":"2018","unstructured":"Andersen A, et al. Glucagon-like peptide 1 in health and disease. Nat Rev Endocrinol. 2018;14(7):390\u2013403.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"618_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100598","volume":"3","author":"T Fuselier","year":"2022","unstructured":"Fuselier T, et al. Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes. Cell Rep Med. 2022;3(4): 100598.","journal-title":"Cell Rep Med"},{"issue":"3","key":"618_CR155","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-014-3478-3","volume":"58","author":"RW Schwenk","year":"2015","unstructured":"Schwenk RW, et al. GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice. Diabetologia. 2015;58(3):604\u201314.","journal-title":"Diabetologia"},{"key":"618_CR156","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.1038\/srep10211","volume":"5","author":"JP Tiano","year":"2015","unstructured":"Tiano JP, et al. Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis. Sci Rep. 2015;5:10211.","journal-title":"Sci Rep"},{"issue":"2","key":"618_CR157","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","volume":"2","author":"S Sachs","year":"2020","unstructured":"Sachs S, et al. Targeted pharmacological therapy restores beta-cell function for diabetes remission. Nat Metab. 2020;2(2):192\u2013209.","journal-title":"Nat Metab"},{"issue":"3","key":"618_CR158","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1258\/0007142001903382","volume":"56","author":"DW Purdie","year":"2000","unstructured":"Purdie DW. Consequences of long-term hormone replacement therapy. Br Med Bull. 2000;56(3):809\u201323.","journal-title":"Br Med Bull"},{"issue":"3","key":"618_CR159","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.CIR.0000045671.62860.98","volume":"107","author":"MK Rutter","year":"2003","unstructured":"Rutter MK, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham heart study. Circulation. 2003;107(3):448\u201354.","journal-title":"Circulation"},{"issue":"3","key":"618_CR160","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"618_CR161","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3389\/fphar.2018.01227","volume":"9","author":"B Zhang","year":"2018","unstructured":"Zhang B, et al. Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor alpha and its downstream signaling. Front Pharmacol. 2018;9:1227.","journal-title":"Front Pharmacol"},{"issue":"10","key":"618_CR162","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","volume":"47","author":"LG Olsson","year":"2006","unstructured":"Olsson LG, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-assessment of reduction in mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47(10):1997\u20132004.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"618_CR163","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/eurjhf\/hfr066","volume":"13","author":"GC Linssen","year":"2011","unstructured":"Linssen GC, et al. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. 2011;13(10):1111\u201320.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"618_CR164","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","volume":"7","author":"R Zakeri","year":"2014","unstructured":"Zakeri R, et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014;7(1):123\u201330.","journal-title":"Circ Heart Fail"},{"issue":"10","key":"618_CR165","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","volume":"128","author":"R Zakeri","year":"2013","unstructured":"Zakeri R, et al. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation. 2013;128(10):1085\u201393.","journal-title":"Circulation"},{"issue":"48","key":"618_CR166","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","volume":"39","author":"B Zafrir","year":"2018","unstructured":"Zafrir B, et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European society of cardiology heart failure long-term registry. Eur Heart J. 2018;39(48):4277\u201384.","journal-title":"Eur Heart J"},{"issue":"4","key":"618_CR167","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00392-014-0788-x","volume":"104","author":"S Meyer","year":"2015","unstructured":"Meyer S, et al. Sex differences in new-onset heart failure. Clin Res Cardiol. 2015;104(4):342\u201350.","journal-title":"Clin Res Cardiol"},{"issue":"23","key":"618_CR168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021563","volume":"133","author":"R Providencia","year":"2016","unstructured":"Providencia R, Lambiase PD. Letter by providencia and lambiase regarding article, atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(23): e691.","journal-title":"Circulation"},{"issue":"9","key":"618_CR169","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","volume":"76","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, et al. Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J Am Coll Cardiol. 2020;76(9):1051\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"618_CR170","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","volume":"23","author":"WJ Manning","year":"1994","unstructured":"Manning WJ, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994;23(7):1535\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"618_CR171","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","volume":"30","author":"DM Clark","year":"1997","unstructured":"Clark DM, et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30(4):1039\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"618_CR172","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0735-1097(98)00221-6","volume":"32","author":"M Pozzoli","year":"1998","unstructured":"Pozzoli M, et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 1998;32(1):197\u2013204.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"618_CR173","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","volume":"49","author":"V Melenovsky","year":"2007","unstructured":"Melenovsky V, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling\/dysfunction. J Am Coll Cardiol. 2007;49(2):198\u2013207.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"618_CR174","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.carpath.2007.12.003","volume":"17","author":"C Knackstedt","year":"2008","unstructured":"Knackstedt C, et al. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovasc Pathol. 2008;17(5):318\u201324.","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"618_CR175","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","volume":"8","author":"V Melenovsky","year":"2015","unstructured":"Melenovsky V, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail. 2015;8(2):295\u2013303.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"618_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065795","volume":"8","author":"J Ball","year":"2013","unstructured":"Ball J, et al. Women versus men with chronic atrial fibrillation: insights from the standard versus atrial fibrillation spEcific managemenT studY (SAFETY). PLoS One. 2013;8(5): e65795.","journal-title":"PLoS One"},{"issue":"8","key":"618_CR177","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","volume":"27","author":"J Heeringa","year":"2006","unstructured":"Heeringa J, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949\u201353.","journal-title":"Eur Heart J"},{"key":"618_CR178","doi-asserted-by":"crossref","unstructured":"Scheuermeyer FX, et al., There are sex differences in the demographics and risk profiles of emergency department (ED) patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes. Acad Emerg Med. 2015; 22(9):1067\u201375.","DOI":"10.1111\/acem.12750"},{"issue":"10","key":"618_CR179","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98(10):946\u201352.","journal-title":"Circulation"},{"issue":"17","key":"618_CR180","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.117.028981","volume":"136","author":"C Magnussen","year":"2017","unstructured":"Magnussen C, et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the biomarCaRE consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017;136(17):1588\u201397.","journal-title":"Circulation"},{"issue":"9989","key":"618_CR181","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015;386(9989):154\u201362.","journal-title":"Lancet"},{"issue":"6","key":"618_CR182","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrcardio.2016.45","volume":"13","author":"D Ko","year":"2016","unstructured":"Ko D, et al. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016;13(6):321\u201332.","journal-title":"Nat Rev Cardiol"},{"key":"618_CR183","doi-asserted-by":"crossref","unstructured":"Correction to: Tamoxifen for the prevention of breast cancer: late results of the italian randomized tamoxifen prevention trial among women with hysterectomy. J Natl Cancer Inst. 2024; 116(6):995.","DOI":"10.1093\/jnci\/djae093"},{"issue":"24","key":"618_CR184","first-page":"1954","volume":"103","author":"JA Wong","year":"2017","unstructured":"Wong JA, et al. Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation. Heart. 2017;103(24):1954\u201361.","journal-title":"Heart"},{"key":"618_CR185","doi-asserted-by":"publisher","first-page":"24132","DOI":"10.1038\/srep24132","volume":"6","author":"WC Tsai","year":"2016","unstructured":"Tsai WC, et al. Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: a nationwide cohort study. Sci Rep. 2016;6:24132.","journal-title":"Sci Rep"},{"issue":"12","key":"618_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051580","volume":"7","author":"DM Bretler","year":"2012","unstructured":"Bretler DM, et al. Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction\u2013a nationwide cohort study. PLoS One. 2012;7(12): e51580.","journal-title":"PLoS One"},{"key":"618_CR187","doi-asserted-by":"crossref","unstructured":"Lee J, et al., Clinical impact of hormone replacement therapy on atrial fibrillation in postmenopausal women: a nationwide cohort study. J Clin Med. 2021; 10(23).","DOI":"10.3390\/jcm10235497"},{"issue":"3","key":"618_CR188","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10741-021-10095-9","volume":"27","author":"Y Pan","year":"2022","unstructured":"Pan Y, et al. The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases. Heart Fail Rev. 2022;27(3):837\u201347.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"618_CR189","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40200-023-01332-z","volume":"23","author":"J Jurica","year":"2024","unstructured":"Jurica J, et al. Obesity as a risk factor in atrial fibrillation and heart failure. J Diabetes Metab Disord. 2024;23(1):125\u201334.","journal-title":"J Diabetes Metab Disord"},{"issue":"11","key":"618_CR190","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.amjcard.2017.02.045","volume":"119","author":"WT O\u2019Neal","year":"2017","unstructured":"O\u2019Neal WT, et al. Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction. Am J Cardiol. 2017;119(11):1785\u201390.","journal-title":"Am J Cardiol"},{"issue":"6","key":"618_CR191","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"618_CR192","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/europace\/euy215","volume":"21","author":"KE Odening","year":"2019","unstructured":"Odening KE, et al. Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling. Europace. 2019;21(3):366\u201376.","journal-title":"Europace"},{"issue":"2","key":"618_CR193","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00045391-200303000-00005","volume":"10","author":"M Gokce","year":"2003","unstructured":"Gokce M, et al. Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction. Am J Ther. 2003;10(2):104\u201311.","journal-title":"Am J Ther"},{"issue":"3","key":"618_CR194","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","journal-title":"JAMA"},{"issue":"2","key":"618_CR195","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale AL, et al. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138(2):198\u2013205.","journal-title":"Circulation"},{"issue":"1","key":"618_CR196","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","volume":"10","author":"EL Kessler","year":"2019","unstructured":"Kessler EL, et al. Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease. Biol Sex Differ. 2019;10(1):7.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"618_CR197","doi-asserted-by":"publisher","first-page":"H824","DOI":"10.1152\/ajpheart.00407.2010","volume":"301","author":"AL Reed","year":"2011","unstructured":"Reed AL, et al. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse. Am J Physiol Heart Circ Physiol. 2011;301(3):H824\u201331.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"618_CR198","doi-asserted-by":"crossref","unstructured":"Gevaert AB, et al., Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model. Circ Heart Fail. 2017; 10(6).","DOI":"10.1161\/CIRCHEARTFAILURE.116.003806"},{"issue":"11","key":"618_CR199","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.ultrasmedbio.2013.04.002","volume":"39","author":"SE Koch","year":"2013","unstructured":"Koch SE, et al. Age- and gender-related changes in ventricular performance in wild-type FVB\/N mice as evaluated by conventional and vector velocity echocardiography imaging: a retrospective study. Ultrasound Med Biol. 2013;39(11):2034\u201343.","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"618_CR200","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00424-020-02357-6","volume":"472","author":"MH No","year":"2020","unstructured":"No MH, et al. Effects of aging and exercise training on mitochondrial function and apoptosis in the rat heart. Pflugers Arch. 2020;472(2):179\u201393.","journal-title":"Pflugers Arch"},{"issue":"1","key":"618_CR201","doi-asserted-by":"publisher","first-page":"H304","DOI":"10.1152\/ajpheart.00290.2005","volume":"290","author":"TA Hacker","year":"2006","unstructured":"Hacker TA, et al. Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol. 2006;290(1):H304\u201311.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"618_CR202","doi-asserted-by":"publisher","first-page":"R835","DOI":"10.1152\/ajpregu.00231.2016","volume":"312","author":"S Al-Gburi","year":"2017","unstructured":"Al-Gburi S, et al. Sex-specific differences in age-dependent progression of aortic dysfunction and related cardiac remodeling in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2017;312(5):R835\u201349.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"618_CR203","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","volume":"34","author":"II Joffe","year":"1999","unstructured":"Joffe II, et al. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999;34(7):2111\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"618_CR204","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1038\/s41598-018-20703-8","volume":"8","author":"C Chandramouli","year":"2018","unstructured":"Chandramouli C, et al. Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia. Sci Rep. 2018;8(1):2346.","journal-title":"Sci Rep"},{"key":"618_CR205","doi-asserted-by":"crossref","unstructured":"Huang JP, et al., Exosomal microRNAs miR-30d-5p and miR-126a-5p Are associated with heart failure with preserved ejection fraction in STZ-induced type 1 diabetic rats. Int J Mol Sci. 2022; 23(14).","DOI":"10.3390\/ijms23147514"},{"issue":"21","key":"618_CR206","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.119.042267","volume":"140","author":"D Tong","year":"2019","unstructured":"Tong D, et al. Female sex is protective in a preclinical model of heart failure with preserved ejection fraction. Circulation. 2019;140(21):1769\u201371.","journal-title":"Circulation"},{"issue":"1","key":"618_CR207","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1038\/s41467-022-31544-5","volume":"13","author":"Y Cao","year":"2022","unstructured":"Cao Y, et al. Sex differences in heart mitochondria regulate diastolic dysfunction. Nat Commun. 2022;13(1):3850.","journal-title":"Nat Commun"},{"key":"618_CR208","doi-asserted-by":"crossref","unstructured":"Norheim F, et al., Gene-by-sex interactions in mitochondrial functions and cardio-metabolic traits. Cell Metab. 2019; 29(4):932\u2013949 e4.","DOI":"10.1016\/j.cmet.2018.12.013"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00618-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:21:53Z","timestamp":1741623713000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00618-x","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}